NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.54
+0.35 (2.16%)
Apr 20, 2026, 12:15 PM EDT - Market open
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $556.85 million as of April 20, 2026. Its market cap has increased by 26.31% in one year.
Market Cap
556.85M
Enterprise Value
554.85M
1-Year Change
26.31%
Ranking
Category
Stock Price
$16.54
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $556.85M, an increase of 41.59%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 545.07M | 5.99% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 628.69M |
| BrainsWay | 624.52M |
| Cytek Biosciences | 596.47M |
| Tactile Systems Technology | 587.19M |
| Beta Bionics | 574.18M |
| Pacific Biosciences of California | 513.40M |
| Orthofix Medical | 513.25M |
| Varex Imaging | 507.64M |